No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
EVER240517P22500
- 0.55
- +0.10+22.22%
15min DelayClose May 10 16:00 ET
0.55High0.55Low
0.55Open0.45Pre Close3 Volume26 Open Interest22.50Strike Price165.00Turnover56.41%IV-3.62%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.55Time Value100Contract SizeAmericanOptions Type-0.4105Delta0.2292Gamma43.43Leverage Ratio-0.0527Theta-0.0016Rho-17.83Eff Leverage0.0117Vega
Intraday
- 5D
- 1D
News
Is EverQuote (EVER) Stock Outpacing Its Finance Peers This Year?
Everquote Insider Sold Shares Worth $11,054,074, According to a Recent SEC Filing
David B Blundin, 10% Owner, Director, on May 06, 2024, sold 453,884 shares in Everquote (EVER) for $11,054,074. Following the Form 4 filing with the SEC, Blundin has control over a total of 2,185,791
EverQuote(EVER.US) 10% Shareholder Sells US$11.05 Million in Common Stock
$EverQuote(EVER.US)$ 10% Shareholder BLUNDIN DAVID B sold 453.88K shares of common stock on May 6, 7, 2024 at an average price of $24.35 for a total value of $11.05 million.Source: Announcement What i
EverQuote(EVER.US) 10% Shareholder Sells US$576.01K in Common Stock
$EverQuote(EVER.US)$ 10% Shareholder LINK VENTURES, LLLP sold 23,651 shares of common stock on May 6, 7, 2024 at an average price of $24.35 for a total value of $576.01K. This transaction involves oth
Express News | EverQuote Inc : Raymond James Raises Target Price to $30 From $20
EverQuote First Quarter 2024 Earnings: Beats Expectations
Comments
Investors are ignoring EverQuote's limited growth expectations, paying for exposure despite the risk. The predicted future revenues may not support a positive sentiment for long, placing investments at risk.
Risks To Shareholder Returns Are Elevated At These Prices For EverQuote, Inc. (NASDAQ:EVER)Insider sale below current stock price suggests they see this as a fair value, a potential negative signal. Ownership shows alignment between management and small shareholders, but past sales warn caution before buying.
B Riley Securities has upgraded EVER and QNST to Buy from Neutral, based on optimism about auto insurance recovery and EverQuote's cost-cutting measures, and decision to focus on core competency by leaving health insurance.
Gainers:
• $Belite Bio(BLTE.US$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US$ +7.56% (earnings reports)
• $The Chemours(CC.US$ +7.2% ...
• $Belite Bio(BLTE.US$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $Atkore(ATKR.US$ +12.11% (earnings reports)
• $AST SpaceMobile(ASTS.US$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $Harmonic(HLIT.US$ +7.56% (earnings reports)
• $The Chemours(CC.US$ +7.2% ...
17
4
Upgrades
• $Agora(API.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US$ : Barclays Upgrades to Overweight from Equal Wei...
• $Agora(API.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $argenx SE(ARGX.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $Idacorp(IDA.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $Jakks Pacific(JAKK.US$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $Coca-Cola FEMSA(KOF.US$ : Barclays Upgrades to Overweight from Equal Wei...
12
2
Read more